טוען...
Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?
BACKGROUND: Chondroblastoma is a rare benign cartilaginous bone tumor that represents 1–2% of all primary bone tumors. It is characterized by aggressive growth, possible recurrence after surgical treatment and, in rare cases, metastasis. Surgical management is the primary treatment and includes intr...
שמור ב:
| הוצא לאור ב: | J Bone Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7750402/ https://ncbi.nlm.nih.gov/pubmed/33364155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2020.100342 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|